- Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. van Royen, N., Piek, J.J., Legemate, D.A., Schaper, W., Oskam, J., Atasever, B., Voskuil, M., Ubbink, D., Schirmer, S.H., Buschmann, I., Bode, C., Buschmann, E.E. Vascular medicine (London, England) (2003)